Pain Therapeutic Solutions Market is anticipated to expand from USD 95.47 Billion in 2025 to USD 152.58 Billion by 2036, registering a CAGR of 4.8%. NSAIDs is poised to dominate the drug class segment with a 32.8% share, while Cancer Pain is expected to lead the indication category at 29.6%.